<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Four hematopoietic in vitro cell lines (Hodgkin derived cell lines L428 and L540, Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> line BJAB and the lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> line of T-cell type L735) were transplanted into <z:mp ids='MP_0003815'>nude</z:mp> mice (NMRI nu/nu) intramuscularly and intracerebrally as well </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> bearing mice were treated with intraperitoneal administration of <z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi>, Adriamycin, Etoposid and <z:chebi fb="0" ids="36373">Vindesine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Therapy results in both systems were proven by Student's t-test and significances were compared </plain></SENT>
<SENT sid="3" pm="."><plain>Resistance and sensitivity of cell lines tested in the i.c.-system were largely in accordance with the i.m.-system </plain></SENT>
<SENT sid="4" pm="."><plain>Best results of treatment were achieved with the T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> line L735 treated with <z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi> and Etoposid </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi> induced complete remission of i.m. <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in several cases whereas in the <z:mp ids='MP_0003815'>nude</z:mp> mouse brain the L735 cell relapsed and showed a more aggressive growth and diminished drug sensitivity </plain></SENT>
</text></document>